134872-23-4 Usage
General Description
2-Bromo-5-methylthiopyridine is a chemical compound with the molecular formula C6H6BrNS. It is a heterocyclic organic compound that contains a bromine atom and a methylthio group attached to a pyridine ring. 2-bromo-5-methylthiopyridine is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials science. It is also used as a reagent in organic synthesis to introduce the 2-bromo-5-methylthiopyridine moiety into various molecules. 2-bromo-5-methylthiopyridine is known for its ability to participate in a variety of chemical reactions, making it a versatile tool for medicinal and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 134872-23-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,8,7 and 2 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 134872-23:
(8*1)+(7*3)+(6*4)+(5*8)+(4*7)+(3*2)+(2*2)+(1*3)=134
134 % 10 = 4
So 134872-23-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H6BrNS/c1-9-5-2-3-6(7)8-4-5/h2-4H,1H3
134872-23-4Relevant articles and documents
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)- 5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor
Li, Jin,Lynch, Michael P.,DeMello, Kristin Lundy,Sakya, Subas M.,Cheng, Hengmiao,Rafka, Robert J.,Bronk, Brian S.,Jaynes, Burton H.,Kilroy, Carolyn,Mann, Donald W.,Haven, Michelle L.,Kolosko, Nicole L.,Petras, Carol,Seibel, Scott B.,Lund, Lisa A.
, p. 1805 - 1809 (2005)
The synthesis of a novel canine COX-2 selective inhibitor, 2-(3-difluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, and its in vitro and in vivo profile are described. Pyrazole 8 demonstrated excellent potency and selectivity for canine COX-2
PCSK9 INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 184-185, (2020/07/31)
The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.
NOVEL COMPOUNDS AS GPR119 AGONISTS
-
Paragraph 0607-0609, (2017/10/26)
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
